APA (7th ed.) Citation

N, G., L, G., A, P., N, G., E, C., A, B., . . . R, T. (2018). Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load. PloS one, 13(2), e0191300. https://doi.org/10.1371/journal.pone.0191300

Chicago Style (17th ed.) Citation

N, Galizzi, et al. "Long-term Efficacy and Safety of Rilpivirine Plus Abacavir and Lamivudine in HIV-1 Infected Patients with Undetectable Viral Load." PloS One 13, no. 2 (2018): e0191300. https://doi.org/10.1371/journal.pone.0191300.

MLA (9th ed.) Citation

N, Galizzi, et al. "Long-term Efficacy and Safety of Rilpivirine Plus Abacavir and Lamivudine in HIV-1 Infected Patients with Undetectable Viral Load." PloS One, vol. 13, no. 2, 2018, p. e0191300, https://doi.org/10.1371/journal.pone.0191300.